Calendar

Financial releases

Date Title  
Toggle Summary AbbVie Increases Quarterly Dividend by 12.3 Percent
NORTH CHICAGO, Ill. , Oct. 28, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) increased the company's quarterly cash dividend by 12.3 percent from $0.57 per share to $0.64 per share.  The cash dividend is payable February 15, 2017 to stockholders of record at the close of
Toggle Summary AbbVie Reports Third-Quarter 2016 Financial Results
- Reports Third-Quarter Diluted EPS of $0.97 on a GAAP Basis; Adjusted Diluted EPS of $1.21, Reflecting Growth of 7.1 Percent Over Third-Quarter 2015 - Delivers Third-Quarter Net Revenues of $6.43 Billion on a GAAP Basis; Adjusted Net Revenues Grew 8.0 Percent on an Operational Basis - Revenue
Toggle Summary AbbVie to Host Third-Quarter Earnings Conference Call
NORTH CHICAGO, Ill. , Oct. 10, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2016 financial results on Friday, October 28, 2016 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 9, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.57 per share.  The cash dividend is payable Nov. 15, 2016 to stockholders of record at the close of business on Oct. 14, 2016 .
Toggle Summary AbbVie to Present at the Morgan Stanley Global Healthcare Conference
NORTH CHICAGO, Ill. , Aug. 30, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 14, 2016 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at 10:40
Toggle Summary AbbVie Reports Second-Quarter 2016 Financial Results
- Reports Second-Quarter Diluted EPS of $0.98 on GAAP Basis; Adjusted Diluted EPS of $1.26, Reflecting Growth of 16.7 Percent Over Second-Quarter 2015 - Delivers Second-Quarter Net Revenues of $6.45 Billion; $6.43 Billion on Adjusted Basis, Reflecting an 18.0 Percent Increase Operationally -
Toggle Summary AbbVie to Host Second-Quarter Earnings Conference Call
NORTH CHICAGO, Ill. , July 1, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its second-quarter 2016 financial results on Friday, July 29, 2016 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , June 16, 2016 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.57 per share.  The cash dividend is payable Aug. 15, 2016 to stockholders of record at the close of business on July 15, 2016 .
Toggle Summary AbbVie to Highlight its Innovative Pipeline to the Investment Community
- AbbVie is dedicated to delivering innovative new therapies that significantly advance the standard of care - AbbVie's late- and early-stage pipelines will drive long-term sustainable performance - AbbVie's late-stage pipeline has the potential to deliver more than 20 new medicines or indications
Toggle Summary AbbVie to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
NORTH CHICAGO, Ill. , May 31, 2016 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 37 th Annual Global Healthcare Conference on Thursday, June 9, 2016 . Bill Chase , executive vice president and chief financial officer, will participate in a question and answer session at